TrialReader


Effect of Caffeine on Time to Anesthetic Emergence After Laparoscopic Cholecystectomy : Randomized-controlled Trial

NCT05079880 — Phase 2, Unknown, 60 participants, Tunis University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT05079880
StatusUnknown
PhasePhase 2
Study typeInterventional; randomized, sequential, masking: double, treatment
Enrollment60 (Estimated)
SponsorTunis University (Other)
ConditionsLaparoscopic Cholecystectomy
Interventions300 mg of caffeine citrate infusion, Placebo (Drug)
Datesstart 2021-08-15, primary completion 2021-10-15 (estimated), completion 2021-10-30 (estimated), first posted 2021-10-15, last updated 2021-10-15
Locations1 site in Tunisia

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Laparoscopic Cholecystectomy All trials of 300 mg of caffeine citrate infusion All trials of Placebo

-Summary

A faster emergence from general anesthesia has a double medico-economic impact by reducing the risks of complications and optimizing the performance of surgical units. No drug has been retained for its ability to actively accelerate anesthetic emergence by antagonizing hypnotics. Thus, the aim of this study was to examine the effect of caffeine on the time to emerge from sevoflurane anesthesia for laparoscopic cholecystectomy.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
GC groupExperimentalDrug: 300 mg of caffeine citrate infusionreceived 300 mg of caffeine citrate infusion
GS groupPlacebo comparatorDrug: PlaceboEquivalent saline infusion
  • 300 mg of caffeine citrate infusion (Drug): At the end of the surgery, the study drug was given intravenously over ten minutes than the sevoflurane infusion was stopped corresponding to the start of the recovery period
  • Placebo (Drug): At the end of the surgery, the placebo was given intravenously over ten minutes than the sevoflurane infusion was stopped corresponding to the start of the recovery period

+Outcome measures

Primary outcomes

  • anesthetic recovery time [Postoperative]: time to return to spontaneous breathing, eye opening on verbal command and time for extubation

Secondary outcomes

  • plasma caffeine levels at H1 and H24 [Hour 1 and Hour 24]
  • postoperative rehabilitation [24 hours postoperatively]: incidence of headache, nausea and vomiting, tiredness score, time to the first flatus and satisfaction of patients
  • postoperative pain (Visual Analog Scale score 0 "no pain" to 10 "severe pain") and consumption of morphine [24 hours postoperatively]

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* American society of Anesthesiologists (ASA) I and II patients, aged older than 18 years old and scheduled for laparoscopic cholecystectomy

Exclusion Criteria:

* Patient with an allergy to caffeine citrate and analgesics used during postoperative period, those with severe renal or hepatic failure, those who refused to participate in addition to patient with heart rhythm disorder, seizure disorder, hypertension, alcoholic or psychiatric illness

+Locations (1)

FacilityCityCountryStatus
Habib Thameur HospitalTunisTunisiaRecruiting

My Notes